HIV can infect its first cells within one hour of exposure and spread beyond the initial site within 24 hours. From that point, the virus moves remarkably fast, reaching peak levels in the blood within two to four weeks and establishing a permanent foothold in the body within days. Here’s what that timeline looks like in detail.
The First 24 Hours
When HIV enters the body, typically through mucosal tissue during sexual contact or directly into the bloodstream, it wastes no time. Animal studies show that initial infection of cells at the exposure site can happen within one hour. The virus first crosses the mucosal barrier and infects a small founder population of immune cells right at the entry point.
Specialized immune cells called dendritic cells play an ironic role here. Their normal job is to patrol mucosal surfaces for invaders and carry them to lymph nodes to trigger an immune response. HIV hijacks this system, essentially getting a ride inside dendritic cells straight to the lymph nodes, where it encounters massive numbers of the immune cells it prefers to infect. Within 24 hours of exposure, the virus can disseminate from the entry point to regional lymph nodes, and at that point, systemic infection begins.
Days 1 Through 7: Gut Destruction Begins
One of the most striking discoveries in HIV research is how quickly the virus attacks the gut. The intestinal lining contains an enormous concentration of the immune cells HIV targets, and regardless of how someone was exposed (sexually, through blood, or otherwise), the virus reaches these cells and begins destroying them within days.
This early gut damage is severe. The virus selectively wipes out specific immune cell populations that maintain the intestinal barrier, the lining that keeps bacteria and other material in the gut from leaking into the bloodstream. Once those cells are gone, bacteria and their byproducts begin crossing into the body, triggering widespread immune activation that actually helps HIV replicate even faster. This intestinal immune destruction happens long before blood tests would show any drop in overall immune cell counts, which is why early HIV infection can be far more damaging internally than it appears from standard lab work.
The Latent Reservoir: Permanent Within Days
Perhaps the most consequential thing HIV does in its first week is something invisible. The virus inserts its genetic material into the DNA of long-lived immune cells that then go dormant. These sleeping infected cells, known as the latent reservoir, are the reason HIV cannot be cured with current treatments.
Studies in primates show that this reservoir forms within three days of mucosal infection. In humans, an estimated 100,000 to 10 million latently infected cells are established during the first weeks. Because these cells aren’t actively producing virus, they’re invisible to both the immune system and antiretroviral medications. They can persist for decades, reactivating if treatment ever stops. This is why the speed of HIV’s early spread matters so much: by the time most people realize they’ve been exposed, the permanent reservoir already exists.
Weeks 2 Through 8: Peak Viral Load
As HIV replicates explosively in lymph nodes and gut tissue, viral levels in the blood climb rapidly. Viral load typically peaks between two weeks and two months after infection, with enormous quantities of virus circulating in the bloodstream. This peak viremia period is when the infected person is most contagious to others, partly because viral levels are extremely high and partly because the body hasn’t yet produced antibodies against the virus.
This is also when many people experience symptoms for the first time. Acute HIV infection generally develops two to four weeks after exposure and can feel like a bad flu: fever, sore throat, swollen lymph nodes, rash, muscle aches, and fatigue. These symptoms reflect the immune system’s first attempt to fight back. Not everyone notices them, and they’re easy to mistake for other common illnesses. After a few weeks, the immune system partially controls viral replication, symptoms fade, and the virus settles into a lower but steady level of activity.
Why Testing Windows Matter
The speed of HIV’s internal spread runs ahead of testing technology. No test can detect HIV immediately after exposure because the virus needs time to produce enough material in the blood for a test to pick up.
Modern fourth-generation tests, which look for both antibodies and a viral protein called p24 antigen, have shortened the detection window to roughly two weeks after infection. At the two-to-three-week mark, the best-performing rapid tests correctly identify about 78% of infections. By one month, sensitivity reaches 90% or higher, and beyond one month, the top tests catch virtually all infections. Older-style tests that only detect antibodies can take up to three months to turn positive. If you’re concerned about a recent exposure, the type of test and its timing relative to exposure both affect reliability.
The 72-Hour Window for Prevention
Because HIV establishes itself so quickly, post-exposure prevention has a narrow window. Post-exposure prophylaxis (PEP) is a 28-day course of antiretroviral medication that can prevent HIV from taking hold if started within 72 hours of exposure, and the sooner the better. The original study establishing PEP’s effectiveness found an 81% reduction in HIV infection among those who received treatment compared to those who did not.
In more recent studies of over 2,200 people who completed a full PEP course, only one case of HIV was attributed to PEP failure. The other infections that occurred were linked to people continuing risky behavior after finishing PEP, not taking the medication as prescribed, or starting it beyond the 72-hour cutoff. The biology explains why timing is everything: if the virus has already seeded its latent reservoir and spread to lymph nodes and gut tissue, a short course of medication can suppress replication but can’t eliminate cells already harboring viral DNA.
How Speed Varies by Stage
After the acute phase resolves, HIV enters a long period of clinical latency where it continues replicating at lower levels. Without treatment, this stage typically lasts around 10 years, though it varies widely. Throughout this time, the virus slowly depletes immune cells, and the rate of that decline depends on individual factors like genetics, overall health, and the specific strain of HIV involved.
With modern antiretroviral therapy, viral replication can be suppressed to undetectable levels within weeks to months of starting treatment. This effectively halts the progressive immune damage, though the latent reservoir remains. People on effective treatment maintain near-normal immune function and have a near-normal life expectancy. The virus isn’t gone, but its spread through the body is contained to the point where it causes no measurable harm and cannot be transmitted to others.